Cytoplasmic accumulation of NCoR in malignant melanoma: consequences of altered gene repression and prognostic significance
暂无分享,去创建一个
A. Gonzalez-Perez | N. López-Bigas | L. Espinosa | A. Bigas | M. Arumí-Uría | B. Bellosillo | S. Segura | L. Nonell | R. Pujol | J. Bertran | C. Rius | M. Iglesias | F. Gallardo | R. Garcia-Carbonell | A. Padron | A. González-Pérez
[1] M. Kris,et al. Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis , 2014, Cell.
[2] Michael P. Schroeder,et al. IntOGen-mutations identifies cancer drivers across tumor types , 2013, Nature Methods.
[3] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[4] S. Thiyagarajan,et al. MAGE-C2 promotes growth and tumorigenicity of melanoma cells, phosphorylation of KAP1, and DNA damage repair. , 2013, The Journal of investigative dermatology.
[5] G. Pawelec,et al. Hsps are up-regulated in melanoma tissue and correlate with patient clinical parameters , 2013, Cell Stress and Chaperones.
[6] A. Gonzalez-Perez,et al. Functional impact bias reveals cancer drivers , 2012, Nucleic acids research.
[7] D. Bernstein,et al. SERPINE1 expression discriminates site‐specific metastasis in human melanoma , 2012, Experimental dermatology.
[8] Syed Haider,et al. International Cancer Genome Consortium Data Portal—a one-stop shop for cancer genomics data , 2011, Database J. Biol. Databases Curation.
[9] C. Sander,et al. Predicting the functional impact of protein mutations: application to cancer genomics , 2011, Nucleic acids research.
[10] M. Bar‐eli,et al. Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progression. , 2011, Cancer research.
[11] D. Speicher,et al. IL8 and Cathepsin B as Melanoma Serum Biomarkers , 2011, International journal of molecular sciences.
[12] Laurent Gil,et al. Ensembl variation resources , 2010, BMC Genomics.
[13] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[14] I. Fariñas,et al. Vascular niche factor PEDF modulates Notch-dependent stemness in the adult subependymal zone , 2009, Nature Neuroscience.
[15] W. Leenders,et al. Semaphorin 3E expression correlates inversely with Plexin D1 during tumor progression. , 2008, The American journal of pathology.
[16] J. Flores,et al. The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis. , 2008, Cancer cell.
[17] P. Guldberg,et al. The genome and epigenome of malignant melanoma , 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[18] G. Capellá,et al. Aberrant Cytoplasmic Localization of N-CoR in Colorectal Tumors , 2007, Cell cycle.
[19] F. Real,et al. Nuclear IKK activity leads to dysregulated Notch-dependent gene expression in colorectal cancer , 2007, Proceedings of the National Academy of Sciences.
[20] A. Richmond,et al. NF‐κB activation in melanoma , 2006 .
[21] Jianxiang Wang,et al. Nuclear receptor co‐repressor gene localizes to 17p11.2, a frequently deleted band in malignant disorders , 1999, Genes, chromosomes & cancer.
[22] A. Richmond,et al. Enhanced Degradation of I-κBα Contributes to Endogenous Activation of NF-κB in Hs294T Melanoma Cells , 1997 .
[23] A. Eggermont,et al. Differential TIMP3 expression affects tumor progression and angiogenesis in melanomas through regulation of directionally persistent endothelial cell migration , 2013, Angiogenesis.
[24] S. Henikoff,et al. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.
[25] A. Richmond,et al. NF-kappaB activation in melanoma. , 2006, Pigment cell research.
[26] A. Richmond,et al. Enhanced degradation of I-kappaB alpha contributes to endogenous activation of NF-kappaB in Hs294T melanoma cells. , 1997, Cancer research.